Renaissance Technologies’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.87M | Buy |
711,686
+121,647
| +21% | +$490K | ﹤0.01% | 1882 |
|
|
2025
Q1 | $1.61M | Buy |
590,039
+206,853
| +54% | +$565K | ﹤0.01% | 2131 |
|
|
2024
Q4 | $1.63M | Buy |
383,186
+85,486
| +29% | +$363K | ﹤0.01% | 2182 |
|
|
2024
Q3 | $875K | Buy |
297,700
+6,400
| +2% | +$18.8K | ﹤0.01% | 2526 |
|
|
2024
Q2 | $1.01M | Buy |
291,300
+46,600
| +19% | +$162K | ﹤0.01% | 2307 |
|
|
2024
Q1 | $697K | Buy |
244,700
+49,300
| +25% | +$140K | ﹤0.01% | 2703 |
|
|
2023
Q4 | $690K | Sell |
195,400
-194,799
| -50% | -$688K | ﹤0.01% | 2609 |
|
|
2023
Q3 | $1.01M | Buy |
390,199
+182,699
| +88% | +$473K | ﹤0.01% | 2286 |
|
|
2023
Q2 | $818K | Buy |
207,500
+61,400
| +42% | +$242K | ﹤0.01% | 2587 |
|
|
2023
Q1 | $494K | Buy |
146,100
+44,717
| +44% | +$151K | ﹤0.01% | 2897 |
|
|
2022
Q4 | $363K | Buy |
101,383
+53,783
| +113% | +$193K | ﹤0.01% | 3132 |
|
|
2022
Q3 | $192K | Buy |
47,600
+26,000
| +120% | +$105K | ﹤0.01% | 3398 |
|
|
2022
Q2 | $96K | Buy |
+21,600
| New | +$96K | ﹤0.01% | 3862 |
|